Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use of reprogrammed cells to identify therapy for respiratory papillomatosis.
Yuan H, Myers S, Wang J, Zhou D, Woo JA, Kallakury B, Ju A, Bazylewicz M, Carter YM, Albanese C, Grant N, Shad A, Dritschilo A, Liu X, Schlegel R. Yuan H, et al. Among authors: bazylewicz m. N Engl J Med. 2012 Sep 27;367(13):1220-7. doi: 10.1056/NEJMoa1203055. N Engl J Med. 2012. PMID: 23013073 Free PMC article.
Analysis of the Presence and Levels of IgG Antibodies Directed against the S1 Protein Receptor Binding Domain and the N Protein of SARS-CoV-2 in Patients with Multiple Sclerosis Treated with Immunomodulatory Therapies.
Kulikowska J, Kapica-Topczewska K, Gudowska-Sawczuk M, Kulczyńska-Przybik A, Bazylewicz M, Mirończuk A, Czarnowska A, Brola W, Mroczko B, Kochanowicz J, Kułakowska A. Kulikowska J, et al. Among authors: bazylewicz m. Vaccines (Basel). 2024 Feb 29;12(3):255. doi: 10.3390/vaccines12030255. Vaccines (Basel). 2024. PMID: 38543889 Free PMC article.
Multiple sclerosis susceptibility may be associated with the coding rs20541 (R130Q) IL-13 gene polymorphism in the Polish population.
Grunwald C, Adamska-Patruno E, Wawrusiewicz-Kurylonek N, Czarnowska A, Snarska K, Dardzińska-Głębocka A, Kapica-Topczewska K, Mirończuk A, Bazylewicz M, Kochanowicz J, Krętowski A, Kułakowska A, Chorąży M. Grunwald C, et al. Among authors: bazylewicz m. Sci Rep. 2023 Dec 12;13(1):22083. doi: 10.1038/s41598-023-49615-y. Sci Rep. 2023. PMID: 38086930 Free PMC article.
Antibodies against SARS-CoV-2 S and N proteins in relapsing-remitting multiple sclerosis patients treated with disease-modifying therapies.
Kulikowska J, Czarnowska A, Gudowska-Sawczuk M, Kulczyńska-Przybik A, Bazylewicz M, Collins F, Chorąży M, Mroczko B, Kochanowicz J, Kapica-Topczewska K, Kułakowska A. Kulikowska J, et al. Among authors: bazylewicz m. Neurol Neurochir Pol. 2023;57(1):121-130. doi: 10.5603/PJNNS.a2022.0067. Epub 2022 Nov 24. Neurol Neurochir Pol. 2023. PMID: 36421067 Free article.
Analysis of Side Effects Following Vaccination Against COVID-19 Among Individuals With Multiple Sclerosis Treated With DMTs in Poland.
Czarnowska A, Tarasiuk J, Zajkowska O, Wnuk M, Marona M, Nowak K, Słowik A, Jamroz-Wiśniewska A, Rejdak K, Lech B, Popiel M, Rościszewska-Żukowska I, Perenc A, Bartosik-Psujek H, Świderek-Matysiak M, Siger M, Ciach A, Walczak A, Jurewicz A, Stasiołek M, Kania K, Dyczkowska K, Kalinowska-Łyszczarz A, Galus W, Walawska-Hrycek A, Krzystanek E, Chojdak-Łukasiewicz J, Ubysz J, Pokryszko-Dragan A, Kapica-Topczewska K, Chorąży M, Bazylewicz M, Mirończuk A, Kulikowska J, Kochanowicz J, Białek M, Stolarz M, Kubicka-Bączyk K, Niedziela N, Warmus P, Adamczyk-Sowa M, Podlecka-Piçtowska A, Nojszewska M, Zakrzewska-Pniewska B, Jasińska E, Zaborski J, Milewska-Jȩdrzejczak M, Zwiernik J, Zwiernik B, Potemkowski A, Brola W, Kułakowska A. Czarnowska A, et al. Among authors: bazylewicz m. Front Neurol. 2022 Jun 14;13:913283. doi: 10.3389/fneur.2022.913283. eCollection 2022. Front Neurol. 2022. PMID: 35775049 Free PMC article.
Safety of Vaccines against SARS-CoV-2 among Polish Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies.
Czarnowska A, Tarasiuk J, Zajkowska O, Wnuk M, Marona M, Nowak K, Słowik A, Jamroz-Wiśniewska A, Rejdak K, Lech B, Popiel M, Rościszewska-Żukowska I, Perenc A, Bartosik-Psujek H, Świderek-Matysiak M, Siger M, Ciach A, Walczak A, Jurewicz A, Stasiołek M, Kania K, Dyczkowska K, Kalinowska-Łyszczarz A, Galus W, Walawska-Hrycek A, Krzystanek E, Chojdak-Łukasiewicz J, Ubysz J, Pokryszko-Dragan A, Kapica-Topczewska K, Chorąży M, Bazylewicz M, Mirończuk A, Kulikowska J, Kochanowicz J, Białek M, Stolarz M, Kubicka-Bączyk K, Niedziela N, Morawiec N, Adamczyk-Sowa M, Podlecka-Piętowska A, Nojszewska M, Zakrzewska-Pniewska B, Jasińska E, Zaborski J, Milewska-Jędrzejczak M, Zwiernik J, Zwiernik B, Potemkowski A, Brola W, Kułakowska A. Czarnowska A, et al. Among authors: bazylewicz m. Vaccines (Basel). 2022 May 12;10(5):763. doi: 10.3390/vaccines10050763. Vaccines (Basel). 2022. PMID: 35632519 Free PMC article.
19 results